DK1763520T3 - Anvendelse af trisubstituerede benzopyranoner - Google Patents
Anvendelse af trisubstituerede benzopyranonerInfo
- Publication number
- DK1763520T3 DK1763520T3 DK05756337T DK05756337T DK1763520T3 DK 1763520 T3 DK1763520 T3 DK 1763520T3 DK 05756337 T DK05756337 T DK 05756337T DK 05756337 T DK05756337 T DK 05756337T DK 1763520 T3 DK1763520 T3 DK 1763520T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzopyranones
- trisubstituted
- trisubstituted benzopyranones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004032440A DE102004032440B4 (de) | 2004-07-05 | 2004-07-05 | Verwendung von trisubstituierten Benzopyranonen |
| PCT/EP2005/007051 WO2006002918A2 (de) | 2004-07-05 | 2005-06-30 | Verwendung von trisubstituierten benzopyranonen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1763520T3 true DK1763520T3 (da) | 2009-02-09 |
Family
ID=35612964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05756337T DK1763520T3 (da) | 2004-07-05 | 2005-06-30 | Anvendelse af trisubstituerede benzopyranoner |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20080020068A1 (ru) |
| EP (1) | EP1763520B1 (ru) |
| JP (1) | JP2008505064A (ru) |
| KR (1) | KR20070038988A (ru) |
| CN (1) | CN101044132A (ru) |
| AR (1) | AR050908A1 (ru) |
| AT (1) | ATE417842T1 (ru) |
| AU (1) | AU2005259420A1 (ru) |
| BR (1) | BRPI0513017A (ru) |
| CA (1) | CA2570908A1 (ru) |
| DE (3) | DE102004032440B4 (ru) |
| DK (1) | DK1763520T3 (ru) |
| ES (1) | ES2317258T3 (ru) |
| GT (1) | GT200500182A (ru) |
| MX (1) | MXPA06014844A (ru) |
| PA (1) | PA8638301A1 (ru) |
| PE (1) | PE20060528A1 (ru) |
| PL (1) | PL1763520T3 (ru) |
| PT (1) | PT1763520E (ru) |
| RU (1) | RU2383537C2 (ru) |
| TW (1) | TW200612903A (ru) |
| UA (1) | UA88165C2 (ru) |
| UY (1) | UY28976A1 (ru) |
| WO (1) | WO2006002918A2 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1847236B (zh) * | 2006-05-16 | 2011-03-23 | 吉林省西点药业科技发展股份有限公司 | 7,8-二羟基-2-氧代-2h-苯并吡喃类衍生物及合成方法和医药用途 |
| EP2134369B1 (de) * | 2007-04-17 | 2019-01-02 | Dr. Willmar Schwabe GmbH & Co. KG | Verfahren zur herstellung von trockenextrakten aus pelargonium sidoides und pelargonium reniforme |
| EP1982731B1 (de) | 2007-04-17 | 2010-06-16 | Dr. Willmar Schwabe GmbH & Co. KG | Verfahren zur Herstellung von lagerstabilen Lösungen aus Pelargonium-Extrakten |
| US20100168225A1 (en) * | 2007-04-18 | 2010-07-01 | Francois Jean | Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors |
| KR100896453B1 (ko) * | 2007-07-18 | 2009-05-14 | 닥터 빌마르 쉬바베 게엠바하 운트 코 카게 | 페라고늄 시도이데스 시럽 |
| WO2011130692A2 (en) * | 2010-04-16 | 2011-10-20 | Colby Pharmaceutical Company | Androgen induced oxidative stress inhibitors |
| TWI583677B (zh) * | 2012-09-21 | 2017-05-21 | 日本臟器製藥股份有限公司 | 香豆素衍生物 |
| JP6089055B2 (ja) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | クマリン誘導体を含有する医薬 |
| WO2015141775A1 (ja) * | 2014-03-20 | 2015-09-24 | 日本臓器製薬株式会社 | クマリン誘導体を有効成分として含有する治療・予防剤 |
| CN104974122B (zh) * | 2015-07-02 | 2017-03-22 | 云南中烟工业有限责任公司 | 一种源自烟草的香豆素化合物、其制备方法和用途 |
| CN105461676B (zh) * | 2015-11-20 | 2017-12-12 | 上海秉丰生物科技有限公司 | 一种伪麻黄碱类衍生物及其制备方法与应用 |
| WO2017213268A1 (ja) * | 2016-06-10 | 2017-12-14 | 国立大学法人東北大学 | インスリン分泌促進剤又はインスリン抵抗性改善剤 |
| CN111803492B (zh) * | 2020-08-05 | 2022-03-29 | 苏州大学 | 一种香豆素类化合物在制备治疗乙肝药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4111861A1 (de) * | 1991-04-11 | 1992-10-15 | Schwabe Willmar Gmbh & Co | Benzopyranone, verfahren zu ihrer herstellung und verwendung |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
| EP1104672A1 (de) * | 1999-12-02 | 2001-06-06 | Laboratoires Serobiologiques(Societe Anonyme) | Kosmetische und/oder pharmazeutische Zubereitungen |
| US20030175777A1 (en) * | 2002-02-04 | 2003-09-18 | Bonagura Vincent R. | Eleutherosides as adjuncts for vaccines and immune modulation |
-
2004
- 2004-07-05 DE DE102004032440A patent/DE102004032440B4/de not_active Withdrawn - After Issue
- 2004-07-05 DE DE102004063910A patent/DE102004063910B4/de not_active Withdrawn - After Issue
-
2005
- 2005-06-09 TW TW094119109A patent/TW200612903A/zh unknown
- 2005-06-21 UY UY28976A patent/UY28976A1/es unknown
- 2005-06-30 AT AT05756337T patent/ATE417842T1/de active
- 2005-06-30 MX MXPA06014844A patent/MXPA06014844A/es active IP Right Grant
- 2005-06-30 KR KR1020067027823A patent/KR20070038988A/ko not_active Application Discontinuation
- 2005-06-30 UA UAA200612964A patent/UA88165C2/ru unknown
- 2005-06-30 DE DE502005006286T patent/DE502005006286D1/de not_active Revoked
- 2005-06-30 BR BRPI0513017-4A patent/BRPI0513017A/pt not_active IP Right Cessation
- 2005-06-30 ES ES05756337T patent/ES2317258T3/es active Active
- 2005-06-30 US US11/631,393 patent/US20080020068A1/en not_active Abandoned
- 2005-06-30 CN CNA2005800224393A patent/CN101044132A/zh active Pending
- 2005-06-30 CA CA002570908A patent/CA2570908A1/en not_active Abandoned
- 2005-06-30 PL PL05756337T patent/PL1763520T3/pl unknown
- 2005-06-30 DK DK05756337T patent/DK1763520T3/da active
- 2005-06-30 EP EP05756337A patent/EP1763520B1/de not_active Revoked
- 2005-06-30 AU AU2005259420A patent/AU2005259420A1/en not_active Abandoned
- 2005-06-30 RU RU2007104244/04A patent/RU2383537C2/ru not_active IP Right Cessation
- 2005-06-30 PT PT05756337T patent/PT1763520E/pt unknown
- 2005-06-30 WO PCT/EP2005/007051 patent/WO2006002918A2/de active Application Filing
- 2005-06-30 JP JP2007518536A patent/JP2008505064A/ja not_active Withdrawn
- 2005-07-01 GT GT200500182A patent/GT200500182A/es unknown
- 2005-07-04 PA PA20058638301A patent/PA8638301A1/es unknown
- 2005-07-04 AR ARP050102782A patent/AR050908A1/es unknown
- 2005-07-05 PE PE2005000781A patent/PE20060528A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2383537C2 (ru) | 2010-03-10 |
| US20080020068A1 (en) | 2008-01-24 |
| UY28976A1 (es) | 2006-02-24 |
| DE102004032440B4 (de) | 2007-02-08 |
| ATE417842T1 (de) | 2009-01-15 |
| TW200612903A (en) | 2006-05-01 |
| AU2005259420A1 (en) | 2006-01-12 |
| PE20060528A1 (es) | 2006-07-27 |
| GT200500182A (es) | 2006-03-17 |
| PL1763520T3 (pl) | 2009-06-30 |
| BRPI0513017A (pt) | 2008-04-22 |
| AR050908A1 (es) | 2006-12-06 |
| KR20070038988A (ko) | 2007-04-11 |
| CA2570908A1 (en) | 2006-01-12 |
| PT1763520E (pt) | 2009-03-23 |
| MXPA06014844A (es) | 2007-03-26 |
| ES2317258T3 (es) | 2009-04-16 |
| JP2008505064A (ja) | 2008-02-21 |
| CN101044132A (zh) | 2007-09-26 |
| WO2006002918A3 (de) | 2006-05-04 |
| PA8638301A1 (es) | 2006-03-24 |
| DE102004063910B4 (de) | 2006-12-28 |
| EP1763520A2 (de) | 2007-03-21 |
| DE102004063910A1 (de) | 2006-02-09 |
| DE502005006286D1 (de) | 2009-01-29 |
| RU2007104244A (ru) | 2008-08-10 |
| WO2006002918A2 (de) | 2006-01-12 |
| DE102004032440A1 (de) | 2006-02-16 |
| UA88165C2 (en) | 2009-09-25 |
| EP1763520B1 (de) | 2008-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1763520T3 (da) | Anvendelse af trisubstituerede benzopyranoner | |
| DK1720866T3 (da) | Fremgangsmåde | |
| DE602005012267D1 (de) | N von geräten | |
| DK1778618T3 (da) | Syntese af triethylentetraminer | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| DK1940465T3 (da) | Ny anvendelse af anti-IL-1beta-antistoffer | |
| DK2363414T3 (da) | Stedstyret modifikation af FVIII | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK1587542T3 (da) | Anvendelse af anti-CD100-antistoffer | |
| DK1812002T3 (da) | Behandling af mastitis | |
| DK3332789T3 (da) | Cladribinkur til behandling af multipel sklerose | |
| DK1705998T3 (da) | Anvendelse af en carboxypeptidase | |
| SE0400476L (sv) | Komponent | |
| DK1730109T3 (da) | Syntese af pyrrol-2-carbonitriler | |
| DK2301576T3 (da) | Terapeutisk anvendelse af anti-CS1-antistoffer | |
| FR2877833B1 (fr) | Correcteur de lordoses | |
| AT6947U3 (de) | Bob | |
| DK1787450T3 (da) | Udvælgelse af information | |
| DK1753544T3 (da) | Coatingindretning | |
| SE0400022D0 (sv) | New compounds | |
| AT7051U3 (de) | Bob | |
| SE0400254D0 (sv) | New compounds | |
| SE0402595D0 (sv) | Novel use | |
| SE0402599D0 (sv) | Novel use | |
| SE0402602D0 (sv) | Novel use |